Beranda › Leukemia Mieloid Akut › New York › New Rochelle
Uji klinis Leukemia Mieloid Akut di New Rochelle, NY
13 studi untuk Leukemia Mieloid Akut mencari peserta di lokasi sekitar New Rochelle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Menerima pesertaFase 2
- North Shore University Hospital, Manhasset · 9 mi jauhnya
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Menerima pesertaFase 1
- Memorial Sloan Kettering Westchester, Harrison · 5 mi jauhnya
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Memorial Sloan Kettering Westchester, Harrison · 5 mi jauhnya
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- Memorial Sloan Kettering Westchester, Harrison · 5 mi jauhnya
- North Shore University Hospital, Manhasset · 9 mi jauhnya
A Study of CRD3874-SI in People With Leukemia
Menerima pesertaFase 1
- Memorial Sloan Kettering Westchester (All protocol activities), Harrison · 5 mi jauhnya
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
- North Shore University Hospital, Manhasset · 9 mi jauhnya
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Menerima pesertaFase 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauhnya
A Study of Revumenib and Mezigdomide in People With Leukemia
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauhnya
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Menerima pesertaFase 1
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauhnya
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Menerima pesertaFase 1
- Memorial Sloan Kettering Westchester, Harrison · 5 mi jauhnya
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Menerima pesertaFase 1
- Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison · 5 mi jauhnya
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Menerima pesertaFase 1
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauhnya
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Menerima pesertaFase 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi jauhnya
Uji klinis Leukemia Mieloid Akut di kota lain
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA41 studi
- Baldwin Park, CA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA31 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
Studi lain di New Rochelle
- Kanker Payudara38 studi
- Kanker Paru Non-Sel Kecil18 studi
- Kanker Prostat16 studi
- Mieloma Multipel14 studi
- Kanker Kandung Kemih11 studi
- Kanker Paru11 studi
- Kanker Endometrium11 studi
- Kanker Metastatik10 studi
- Kanker (semua jenis)10 studi
- Kanker Ovarium9 studi
- Penyakit Kardiovaskular8 studi
- Kanker Pankreas8 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.